Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30068105HIVENSG00000181072.12protein_codingCHRM2NoNo1129A4D1Q0
P08172
Q6SL56
Q6SL59
Q86SJ1
TVIS30068106HIVENSG00000181072.12protein_codingCHRM2NoNo1129A4D1Q0
P08172
Q6SL56
Q6SL59
Q86SJ1
TVIS20062080HPVENSG00000181072.12protein_codingCHRM2NoNo1129A4D1Q0
P08172
Q6SL56
Q6SL59
Q86SJ1
TVIS20061501HPVENSG00000181072.12protein_codingCHRM2NoNo1129A4D1Q0
P08172
Q6SL56
Q6SL59
Q86SJ1
TVIS20023329HPVENSG00000181072.12protein_codingCHRM2NoNo1129A4D1Q0
P08172
Q6SL56
Q6SL59
Q86SJ1
TVIS20038182HPVENSG00000181072.12protein_codingCHRM2NoNo1129A4D1Q0
P08172
Q6SL56
Q6SL59
Q86SJ1
TVIS20061739HPVENSG00000181072.12protein_codingCHRM2NoNo1129A4D1Q0
P08172
Q6SL56
Q6SL59
Q86SJ1
TVIS20043130HPVENSG00000181072.12protein_codingCHRM2NoNo1129A4D1Q0
P08172
Q6SL56
Q6SL59
Q86SJ1
TCGA Plot Options
Drug Information
GeneCHRM2
DrugBank IDDB01591
Drug NameSolifenacin
Target IDBE0000560
UniProt IDP08172
Regulation Typeantagonist
PubMed IDs20590605; 19029429
CitationsSinha S, Gupta S, Malhotra S, Krishna NS, Meru AV, Babu V, Bansal V, Garg M, Kumar N, Chugh A, Ray A: AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladder. Br J Pharmacol. 2010 Jul;160(5):1119-27. doi: 10.1111/j.1476-5381.2010.00752.x.@@Mansfield KJ, Chandran JJ, Vaux KJ, Millard RJ, Christopoulos A, Mitchelson FJ, Burcher E: Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa. J Pharmacol Exp Ther. 2009 Mar;328(3):893-9. doi: 10.1124/jpet.108.145508. Epub 2008 Nov 24.
GroupsApproved
Direct Classification1-phenyltetrahydroisoquinolines
SMILESO=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1
Pathways
PharmGKBPA164783810
ChEMBLCHEMBL1734